{
    "2021-02-23": [
        [
            {
                "time": "",
                "original_text": "【权益变动】康龙化成(03759-HK)获摩根大通增持16.9163万股",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "摩根大通",
                        "增持",
                        "港股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "小摩增持康龙化成(03759)约16.92万股，每股作价约154.38港元",
                "features": {
                    "keywords": [
                        "小摩",
                        "康龙化成",
                        "增持",
                        "股价",
                        "港元"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：生物类似药相似性评价正式启动",
                "features": {
                    "keywords": [
                        "医药行业",
                        "生物类似药",
                        "相似性评价",
                        "启动"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "JP Morgan Chase & Co.增持康龙化成股份约16.92万股",
                "features": {
                    "keywords": [
                        "JP Morgan Chase",
                        "康龙化成",
                        "增持",
                        "股份"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "南向资金高比例持有港股名单",
                "features": {
                    "keywords": [
                        "南向资金",
                        "港股",
                        "高比例持有"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}